TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00077142
Recruitment Status : Completed
First Posted : February 11, 2004
Last Update Posted : October 31, 2018
National Cancer Institute (NCI)
Taiho Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center